This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ai, M.
Right arrow Articles by Warman, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ai, M.
Right arrow Articles by Warman, M. L.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, June 2005, p. 4946-4955, Vol. 25, No. 12
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.12.4946-4955.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Reduced Affinity to and Inhibition by DKK1 Form a Common Mechanism by Which High Bone Mass-Associated Missense Mutations in LRP5 Affect Canonical Wnt Signaling

Minrong Ai,1 Sheri L. Holmen,2 Wim Van Hul,3 Bart O. Williams,2 and Matthew L. Warman1*

Department of Genetics and Center for Human Genetics, Case School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio,1 Laboratory of Cell Signaling and Carcinogenesis, Van Andel Research Institute, Grand Rapids, Michigan,2 Department of Medical Genetics, University and University Hospital of Antwerp, Antwerp, Belgium3

Received 7 January 2005/ Returned for modification 21 January 2005/ Accepted 16 March 2005

The low-density-lipoprotein receptor-related protein 5 (LRP5), a coreceptor in the canonical Wnt signaling pathway, has been implicated in human disorders of low and high bone mass. Loss-of-function mutations cause the autosomal recessive osteoporosis-pseudoglioma syndrome, and heterozygous missense mutations in families segregating autosomal dominant high bone mass (HBM) phenotypes have been identified. We expressed seven different HBM-LRP5 missense mutations to delineate the mechanism by which they alter Wnt signaling. None of the mutations caused activation of the receptor in the absence of ligand. Each mutant receptor was able to reach the cell surface, albeit at differing amounts, and transduce exogenously supplied Wnt1 and Wnt3a signal. All HBM mutant proteins had reduced physical interaction with and reduced inhibition by DKK1. These data suggest that HBM mutant proteins can transit to the cell surface in sufficient quantity to transduce Wnt signal and that the likely mechanism for the HBM mutations' physiologic effects is via reduced affinity to and inhibition by DKK1.


* Corresponding author. Mailing address: Department of Genetics, BRB-719, Case School of Medicine, 2109 Adelbert Road, Cleveland, OH 44106. Phone: (216) 368-4919. Fax: (216) 368-5857. E-mail: mlw14{at}case.edu.


Molecular and Cellular Biology, June 2005, p. 4946-4955, Vol. 25, No. 12
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.12.4946-4955.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Binnerts, M. E., Tomasevic, N., Bright, J. M., Leung, J., Ahn, V. E., Kim, K.-A., Zhan, X., Liu, S., Yonkovich, S., Williams, J., Zhou, M., Gros, D., Dixon, M., Korver, W., Weis, W. I., Abo, A. (2009). The First Propeller Domain of LRP6 Regulates Sensitivity to DKK1. Mol. Biol. Cell 20: 3552-3560 [Abstract] [Full Text]  
  • Baron, R. (2009). Wnt Signaling, LRP5 and Gut Serotonin: Have We Been Targeting the Right Pathway for the Wrong Reasons?. IBMS BoneKEy 6: 86-93 [Full Text]  
  • Pinzone, J. J., Hall, B. M., Thudi, N. K., Vonau, M., Qiang, Y.-W., Rosol, T. J., Shaughnessy, J. D. Jr (2009). The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood 113: 517-525 [Abstract] [Full Text]  
  • Ellwanger, K., Saito, H., Clement-Lacroix, P., Maltry, N., Niedermeyer, J., Lee, W. K., Baron, R., Rawadi, G., Westphal, H., Niehrs, C. (2008). Targeted Disruption of the Wnt Regulator Kremen Induces Limb Defects and High Bone Density. Mol. Cell. Biol. 28: 4875-4882 [Abstract] [Full Text]  
  • Day, T. F., Yang, Y. (2008). Wnt and Hedgehog Signaling Pathways in Bone Development. JBJS 90: 19-24 [Abstract] [Full Text]  
  • Balemans, W., Van Hul, W. (2007). The Genetics of Low-Density Lipoprotein Receptor-Related Protein 5 in Bone: A Story of Extremes. Endocrinology 148: 2622-2629 [Abstract] [Full Text]  
  • Bodine, P. V. (2007). Wnt Signaling in Bone. IBMS BoneKEy 4: 108-123 [Abstract] [Full Text]  
  • Clines, G. A., Mohammad, K. S., Bao, Y., Stephens, O. W., Suva, L. J., Shaughnessy, J. D. Jr., Fox, J. W., Chirgwin, J. M., Guise, T. A. (2007). Dickkopf Homolog 1 Mediates Endothelin-1-Stimulated New Bone Formation. Mol. Endocrinol. 21: 486-498 [Abstract] [Full Text]  
  • Semenov, M. V., He, X. (2006). LRP5 Mutations Linked to High Bone Mass Diseases Cause Reduced LRP5 Binding and Inhibition by SOST. J. Biol. Chem. 281: 38276-38284 [Abstract] [Full Text]  
  • Ralston, S. H., de Crombrugghe, B. (2006). Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev. 20: 2492-2506 [Abstract] [Full Text]  
  • Sawakami, K., Robling, A. G., Ai, M., Pitner, N. D., Liu, D., Warden, S. J., Li, J., Maye, P., Rowe, D. W., Duncan, R. L., Warman, M. L., Turner, C. H. (2006). The Wnt Co-receptor LRP5 Is Essential for Skeletal Mechanotransduction but Not for the Anabolic Bone Response to Parathyroid Hormone Treatment. J. Biol. Chem. 281: 23698-23711 [Abstract] [Full Text]  
  • Christodoulides, C., Laudes, M., Cawthorn, W. P., Schinner, S., Soos, M., O'Rahilly, S., Sethi, J. K., Vidal-Puig, A. (2006). The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J. Cell Sci. 119: 2613-2620 [Abstract] [Full Text]  
  • Swiatek, W., Kang, H., Garcia, B. A., Shabanowitz, J., Coombs, G. S., Hunt, D. F., Virshup, D. M. (2006). Negative Regulation of LRP6 Function by Casein Kinase I {epsilon} Phosphorylation. J. Biol. Chem. 281: 12233-12241 [Abstract] [Full Text]  
  • van Bezooijen, R. L., Papapoulos, S. E., Hamdy, N. A., ten Dijke, P., Lowik, C. W. (2005). Control of Bone Formation by Osteocytes? Lessons from the Rare Skeletal Disorders Sclerosteosis and van Buchem Disease. IBMS BoneKEy 2: 33-38 [Full Text]